The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
Vlad Constantin Donica,
Anisia Iuliana Alexa,
Irina Andreea Pavel,
Ciprian Danielescu,
Manuela Andreea Ciapă,
Alexandra Lori Donica,
Camelia Margareta Bogdănici
Affiliations
Vlad Constantin Donica
Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, No. 16, 700115 Iasi, Romania
Anisia Iuliana Alexa
Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, No. 16, 700115 Iasi, Romania
Irina Andreea Pavel
Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, No. 16, 700115 Iasi, Romania
Ciprian Danielescu
Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, No. 16, 700115 Iasi, Romania
Manuela Andreea Ciapă
Emergency Hospital “Dimitrie Castroian”, 735100 Husi, Romania
Alexandra Lori Donica
Clinical Recovery Hospital, 700661 Iasi, Romania
Camelia Margareta Bogdănici
Department of Ophthalmology, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street, No. 16, 700115 Iasi, Romania
The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).
